EUVIMEDEUVIMED entdecken
Editorial

From Prescribing to Partnering: Addressing Disparities in Adjuvant Chemotherapy Acceptance for High-Risk Patients With Breast Cancer

Emily L Podany iD, Katherine N Weilbaecher iD, Foluso O Ademuyiwa iD

JCO Oncology Practice · 30.10.2026

DOI: 10.1200/op-26-00638 ↗

Kurz gefasst

Editorial in der Zeitschrift JCO Oncology Practice, online erschienen am 30.10.2026. Verfasst von Emily L Podany und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Washington University in St Louis, St Louis, MO. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medicine, Washington University in St Louis, St Louis, MO.

ORCID-Profile: Emily L Podany, Katherine N Weilbaecher, Foluso O Ademuyiwa

Zitieren

APA

Podany, E. L., Weilbaecher, K. N., & Ademuyiwa, F. O. (2026). From Prescribing to Partnering: Addressing Disparities in Adjuvant Chemotherapy Acceptance for High-Risk Patients With Breast Cancer. JCO Oncology Practice. https://doi.org/10.1200/op-26-00638

Vancouver

Podany EL, Weilbaecher KN, Ademuyiwa FO. From Prescribing to Partnering: Addressing Disparities in Adjuvant Chemotherapy Acceptance for High-Risk Patients With Breast Cancer. JCO Oncology Practice. 2026. doi:10.1200/op-26-00638

BibTeX
@article{Podany2026,
  author = {Podany, Emily L and Weilbaecher, Katherine N and Ademuyiwa, Foluso O},
  title = {From Prescribing to Partnering: Addressing Disparities in Adjuvant Chemotherapy Acceptance for High-Risk Patients With Breast Cancer},
  journal = {JCO Oncology Practice},
  year = {2026},
  doi = {10.1200/op-26-00638}
}
Kostenlos starten →